Saturday - June 20, 2026
Tipoffs for Maine (New England) Newsletter for Tuesday May 02, 2023 ( 7 items )  

DEA-New England Division: New Britain Man Involved in Drug Ring Sentenced to 6 Years in Federal Prison
NEW BRITAIN, Connecticut, May 2 -- The U.S. Department of Justice Drug Enforcement Administration's New England Division issued the following news release on May 1, 2023: Vanessa Roberts Avery, United States Attorney for the District of Connecticut, announced that EDWIN REYES, 40, of New Britain, was sentenced today by U.S. District Judge Victor A. Bolden in Bridgeport to 72 months of imprisonment, followed by five years of supervised release, for trafficking heroin and fentanyl. According to   more

DEA-New England Division: Pennsylvania Man Sentenced to 5 Years in Prison for Fentanyl Trafficking Offense
HARTFORD, Connecticut, May 2 -- The U.S. Department of Justice Drug Enforcement Administration's New England Division issued the following news release on May 1, 2023: Vanessa Roberts Avery, United States Attorney for the District of Connecticut, announced that PEDRO DIAZ, 45, of Red Lion, Pennsylvania, was sentenced today by U.S. District Judge Vanessa L. Bryant in Hartford to 60 months of imprisonment, followed by four years of supervised release, for trafficking fentanyl. According to court  more

EPA Settlements Resolve Alleged Violations of Toxic Chemical Reporting Requirements by Six New England Companies
BOSTON, Massachusetts, May 2 -- The Environmental Protection Agency issued the following news release on May 1, 2023: The U.S. Environmental Protection Agency (EPA) today announced settlements with six New England companies that resolve alleged violations of the Emergency Planning and Community Right To Know Act, which requires companies and organizations to report their use and release of toxic chemicals to EPA's Toxic Release Inventory (TRI) Program. The companies are Franklin Foods of Enosb  more

House Transportation & Infrastructure Committee Issues Testimony From Rep. Magaziner at Member Day Hearing on Transportation & Infrastructure Priorities
WASHINGTON, April 29 -- The House Transportation and Infrastructure Committee issued the following testimony by Rep. Seth Magaziner, D-Rhode Island, at an April 18, 2023, member day hearing on transportation and infrastructure priorities: * * * Dear Chairman Graves and Ranking Member Larsen: Thank you for the opportunity to offer testimony to the Transportation and Infrastructure Committee and elevate Rhode Islanders' priorities as you prepare to reauthorize federal aviation programs. The Ocea  more

NIH: "Eat, Sleep, Console" Reduces Hospital Stay and Need for Medication Among Opioid-Exposed Infants
WASHINGTON, May 2 (TNSjou) -- The U.S. Department of Health and Human Services' National Institutes of Health issued the following news release: Researchers have found the "Eat, Sleep, Console" (ESC) care approach to be more effective than using the Finnegan Neonatal Abstinence Scoring Tool (FNAST) to assess and manage opioid-exposed newborns, according to a national, randomized controlled clinical trial funded by the National Institutes of Health. Newborns cared for with ESC were medically rea  more

SGO Communique: Considerations When Treating Cervical, Vulvar, and Vaginal Cancers in the Setting of Cisplatin and Carboplatin Shortages
CHICAGO, Illinois, May 2 (TNSres) -- The Society of Gynecologic Oncology issued the following news release: A platinum drug shortage in the US was first reported to the FDA on February 10th, 2023. Please refer to the SGO Rapid Communique dated April 21st, 2023 for details and guidance regarding platinum dosing and sparing strategies. This communication provides guidance for treating patients with cervical, vulvar, or vaginal cancers in the context of limited drug availability. Hospital systems  more

UAMS, NIH Study Finds Consoling, Other Techniques Better Than Drug Therapies for Newborns With Opioid Withdrawal
LITTLE ROCK, Arkansas, May 2 (TNSjou) -- The University of Arkansas's School of Medical Sciences issued the following news release: A groundbreaking nationwide clinical trial in which the University of Arkansas for Medical Sciences (UAMS) played a key role has confirmed an effective way to wean newborns from opioid withdrawal symptoms that substantially reduces hospital stays and the traditional use of drug therapies. Using an "Eat, Sleep, Console" (ESC) care approach resulted in infants with   more